Get started
Author

Alfredo Matias Rodriguez-Granillo

Observed names: A M Rodriguez-Granillo, A M Rodríguez-Granillo, A Matias Rodriguez-Granillo, A Matías Rodríguez-Granillo, A. Matias Rodriguez‐Granillo, A. Matías Rodriguez-Granillo, A. Matías Rodríguez-Granillo, A. Rodriguez-Granillo, A.M. Rodriguez-Granillo, ALFREDO MATÍAS RODRÍGUEZ GRANILLO, AM Rodríguez Granillo, AM Rodríguez-Granillo, Alfredo E Rodríguez, Alfredo M Rodriguez-Granillo, Alfredo M Rodríguez Granillo, Alfredo M Rodríguez-Granillo, Alfredo M. RODRIGUEZ-GRANILLO, Alfredo M. Rodriguez Granillo, Alfredo M. Rodriguez-Granillo, Alfredo M. Rodriguez‐Granillo, Alfredo M. Rodriguez–Granillo, Alfredo M. Rodríguez-Granillo, Alfredo Matias M Rodriguez-Granillo, Alfredo Matías Rodriguez Granillo, Alfredo Matías Rodriguez-Granillo, Alfredo Matías Rodríguez Granillo, Alfredo Matías Rodríguez-Granillo, Alfredo Rodriguez Granillo, Matías A. Rodríguez Granillo, Matías Rodríguez Granillo
ORCID: 0000-0002-5156-3810
Observed ORCID: 0000-0002-5156-3810
OpenAlex ID: A5010285164
Comparison of AngioJet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting With Direct Stenting Alone in Patients With Acute Myocardial Infarction
2010 · Angela Migliorini, Amerigo Stabile, et al. · Journal of the American College of Cardiology · 196
Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis
2006 · Alfredo E. Rodriguez, Juan F. Granada, et al. · Journal of the American College of Cardiology · 98
Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry
2007 · A. E. Rodriguez, A. O. Maree, et al. · European Heart Journal · 89
Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis
2024 · Walter Masson, Martín Lobo, et al. · Frontiers in Cardiovascular Medicine · 69
Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease
2016 · David M. Charytan, Manisha Desai, et al. · Kidney International · 54
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial.
2006 · Alfredo E Rodriguez, Liliana Grinfeld, et al. · PubMed · 40
One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: Results from the DiabEtic Argentina Registry (DEAR)
2012 · Juan Mieres, Carlos Fernandez-Pereira, et al. · Cardiovascular revascularization medicine · 28
Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study
2009 · Alfredo Rodriguez, Andrew Maree, et al. · EuroIntervention · 26
Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two‐year follow‐up of the observational, prospective, controlled, and multicenter ERACI IV registry
2016 · Carlos Haiek, Carlos Fernández‐Pereira, et al. · Catheterization and Cardiovascular Interventions · 22
Randomized comparison of cost‐saving and effectiveness of oral rapamycin plus bare‐metal stents with drug‐eluting stents: Three‐year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial
2011 · Alfredo E. Rodriguez, Alfredo M. Rodriguez‐Granillo, et al. · Catheterization and Cardiovascular Interventions · 19
Comparison of Cost-Effectiveness of Oral Rapamycin Plus Bare-Metal Stents Versus First Generation of Drug-Eluting Stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 Trial)
2013 · Alfredo E. Rodriguez, Igor Palacios, et al. · The American Journal of Cardiology · 14
Efficacy and safety of a double‐coated paclitaxel‐eluting coronary stent: The EUCATAX trial
2010 · Alfredo E. Rodriguez, Cesar F. Vigo, et al. · Catheterization and Cardiovascular Interventions · 14
PDF
Second vs. first-generation drug-eluting stents in complex lesions subsets: 3 years' follow-up of ERACI IV study
2016 · Alfredo E. Rodriguez, on behalf of ERACI IV Investigators, et al. · Minerva Cardiology and Angiology · 13
Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis
2018 · Alfredo E. Rodriguez, Alfredo M. Rodriguez-Granillo, et al. · Current Pharmaceutical Design · 9
Lowering risk score profile during PCI in multiple vessel disease is associated with low adverse events: The ERACI risk score
2018 · Alfredo E. Rodriguez, Carlos Fernandez-Pereira, et al. · Cardiovascular revascularization medicine · 8
New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.
2009 · Gilberto Perez, Alfredo M Rodriguez-Granillo, et al. · PubMed · 8
Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortium
2024 · Alfredo Matías Rodriguez-Granillo, Leonardo Solórzano, et al. · Frontiers in Cardiovascular Medicine · 6
High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data
2023 · Alfredo E. Rodriguez, Carlos Fernandez-Pereira, et al. · Diagnostics · 6
PDF
Is non-cardiac death increased with an initial invasive revascularization strategy? Commentary on the ISCHEMIA trial
2022 · Alfredo E Rodriguez, Carlos Fernandez-Pereira, et al. · European Heart Journal Open · 5
PDF
Ventricular Septal Perforation after Biventricular Takotsubo Cardiomyopathy Successfully Repaired with an Amplatzer Device: First Report in the Literature
2016 · Alfredo E. Rodríguez, Carlos Fernandez-Pereira, et al. · Case Reports in Cardiology · 5
PDF
Changes in the safety paradigm with percutaneous coronary interventions in the modern era: Lessons learned from the ASCERT registry
2012 · Alfredo E Rodríguez · World Journal of Cardiology · 5
PDF
Randomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) Trial
2025 · Alfredo Matias Rodriguez-Granillo, Juan Mieres, et al. · Journal of Clinical Medicine · 4
PDF
Randomized Comparison Between bare-metal Stent Plus Colchicine Versus drug-eluting Stent Alone in Prevention of Clinical Adverse Events After Percutaneous Coronary Intervention
2020 · Camila Correa-Sadouet, A Matías Rodríguez-Granillo, et al. · Future Cardiology · 4
One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers Study
2019 · Alfredo E Rodriguez, Miguel Larribau, et al. · Clinical Medicine Insights Cardiology · 4
Revascularization strategies for patients with multiple vessel coronary disease and unprotected left main. A prospective, multicenter and controlled Argentina registry with a cobalt-chromium rapamycin eluting stent, FIREBIRD 2™: protocol design and methods of the ERACI IV Registry
2014 · Alfredo E Rodríguez, Carlos Fernández-Pereira, et al. · Revista Argentina de Cardioangiología Intervencionista · 4
PDF
Works count: 65
Citation count: 764
H-index: 13
I10-index: 13
Year
Topic
Type